Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extrapyramidal side effects are unacceptable.

J M Kane1

  • 1Department of Psychiatry, Hillside Hospital, 59-75 263rd Street, Glen Oakes, New York, NY 11004, USA.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|October 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Canadian Surgery Forum: Abstracts of presentations to the Annual Meetings of the Canadian Association of Bariatric Physicians and Surgeons, Canadian Association of General Surgeons, Canadian Association of Thoracic Surgeons, Canadian Hepato-Pancreato-Biliary Society, Canadian Society of Surgical Oncology, Canadian Society of Colon and Rectal Surgeons, London, Ont. Sept. 15-18, 2011.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

How and when to use clozapine.

Acta psychiatrica Scandinavica·2019
Same author

Detecting relapse in youth with psychotic disorders utilizing patient-generated and patient-contributed digital data from Facebook.

NPJ schizophrenia·2019
Same author

Clozapine as an early-stage treatment.

Acta psychiatrica Scandinavica·2018
Same author

Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.

Acta psychiatrica Scandinavica·2018
Same author

Abnormalities of gait caused by ankle arthritis are improved by ankle arthrodesis.

The bone & joint journal·2016
Same journal

Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Corrigendum to "Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults" [European Neuropsychopharmacology, 112, 112887].

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Variability in AI-generated psychedelic definitions across major chatbots.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

In-patient treatment and structural dysconnectivity in major depression - A longitudinal connectome study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
See all related articles

New antipsychotic medications significantly reduce extrapyramidal side effects (EPS) compared to older drugs. This improvement enhances patient compliance and treatment outcomes, offering a safer alternative for managing psychiatric conditions.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Medicine

Background:

  • Extrapyramidal side effects (EPS) are a significant limitation of conventional antipsychotic medications.
  • These side effects cause patient distress, reduce treatment adherence, and negatively impact outcomes.
  • Conventional antipsychotics, like haloperidol, are associated with a high incidence of EPS.

Purpose of the Study:

  • To evaluate the impact of new-generation atypical antipsychotics on extrapyramidal side effects.
  • To compare the incidence of EPS between atypical antipsychotics and conventional agents.
  • To assess the long-term risk of tardive dyskinesia with newer antipsychotic treatments.

Main Methods:

  • Review of clinical trial data comparing atypical antipsychotics with conventional antipsychotics.

Related Experiment Videos

  • Analysis of studies assessing early- and late-occurring EPS.
  • Examination of long-term data on tardive dyskinesia risk.

    • Main Results:

    • Atypical antipsychotics demonstrate a notable reduction in both early- and late-occurring EPS compared to haloperidol.
    • New-generation agents require less concomitant antiparkinsonian medication.
    • Long-term studies indicate a decreased risk of tardive dyskinesia, especially in elderly populations.

    Conclusions:

    • Atypical antipsychotics offer a superior safety profile regarding extrapyramidal side effects.
    • The reduced EPS burden associated with newer agents can improve patient compliance and treatment efficacy.
    • Atypical antipsychotics represent a significant advancement in managing psychiatric disorders with fewer motor-related adverse effects.